Cardiomyocyte swelling occurs in multiple pathological situations and has been associated with contractile dysfunction, cell death, and enhanced propensity to arrhythmias. We investigate whether hypotonic swelling promotes nitric oxide (NO) release in cardiomyocytes, and whether it impacts on swelling-induced contractile dysfunction.
Introduction
Tissue osmolarity is tightly regulated under physiological conditions. 1 However, under diverse pathological situations, cells undergo hypotonic swelling 2 -4 that dilutes intracellular components and deforms cellular membranes and the underlying cytoskeleton. This results in changes in the activity of signalling molecules and ion channels leading to alterations in cellular function. In the heart, cell swelling occurs in diabetic or septic shock and elective cardioplegia, and is particularly important in the context of ischaemia and reperfusion (I/R) where it results in structural, ionic, and electrical remodelling that have been shown to contribute to contractile dysfunction, cell death, and enhanced propensity for arrhythmias.
the cochlea. 7, 8 However, whether hypotonic swelling can promote NO release in cardiac ventricular myocytes has not been established. Thus, the present study was designed to examine whether cardiomyocyte hypotonic swelling is associated with NO release and if so, to determine its functional implications on the swelling-induced negative inotropic response.
Using an NO-sensitive fluorescent dye, we show for the first time that hypotonic swelling-induced cytoskeleton deformation leads to NOS1-dependent NO release in cardiomyocytes. This NO, through a cGMP/PKG-dependent mechanism, provides inotropic support that could reduce the impact of hypotonic swelling-induced contractile dysfunction.
Methods
All experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, revised 1996) and approved by the Institutional Animal Care and Use Committee of La Plata University.
Myocyte isolation
Male Wistar rats (200 -300 g) were anaesthetised by an intraperitoneal injection of sodium pentobarbitone (35 mg/kg body weight) and hearts were excised when plane three of phase III of anaesthesia was reached. Plane three of phase III of anaesthesia was verified by the presence of slow deep diaphragmatic breathing, loss of the corneal reflex, and the absence of tongue retraction.
Cardiomyocytes were isolated by collagenase-based enzymatic digestion using a previously described technique. 9 Using a similar protocol, myocytes were isolated from 3-month-old C57BL/6 (WT, Jackson Laboratories, Bar Harbor, ME, USA) and transgenic mice with homozygous deletions for NOS1 bred on a C57BL/6 background (NOS1KO, Jackson Laboratories).
Experimental protocol
Myocytes were field stimulated by external platinum electrodes at 0.5 Hz and superfused (1 mL/min at room temperature) with isotonic solution (IS, 309 mOsm) during 5 min and then exposed to hypotonic solution (HS, 217 mOsm). For control experiments, cardiomyocytes were kept in IS throughout the experiment. These HEPES-buffered solutions were prepared as previously described by others. 10 In brief: HS (in mmol/L): NaCl 91, KCl 5.3, MgCl 2 0.5, CaCl 2 1, glucose 10, and HEPES 10, titrated to pH 7.4; IS: HS + mannitol 91.5 mM.
Measurement of intracellular NO and cell width in cardiomyocytes
Cardiomyocytes were loaded with 5 mM 4-amino-5-methylamino-2 ′ ,7 ′ -difluorofluorescein diacetate (DAF-FM) diacetate (Molecular Probes) for 30 min, and imaged by epifluorescence on a Zeiss 410 inverted confocal microscope (LSM Tech, Wellsville, PA, USA). Excitation at 488 nm was provided by an argon laser and emission was collected in a range of 510 -530 nm. Fluorescence was acquired for 2.5 s at 5 min intervals over the duration of 25 min. To minimize photobleaching, the lowest possible laser intensity was used. In parallel, we acquired brightfield images to measure cell width which was used as an estimation of the degree of cell swelling. 10 
Cell membrane and T-tubular system imaging
After 20 min treatment with IS or HS, cells were loaded with di-8-aminonaphthylethenylpyridinium (Di-8-ANNEPS, 5 mM; Molecular Probes) for 2 min.
11 Fluorescent images were acquired by exciting with an Argon laser at 488 nm. Emission was collected at 560 nm.
In images from Di-8-ANNEPS-stained myocytes, we performed quantitative analysis of T-tubular (TT) architecture using the Auto TT analysis program, kindly provided by Dr Long-Sheng Song, Iowa University. 12 
Calcium transient and cell shortening measurement
Myocytes were loaded with 10 mM fura-2-acetoxymethyl ester during 12 min. Fura-2 fluorescence was measured on an inverted microscope adapted for epifluorescence by an IonOptix hardware. The ratio of the Fura-2 fluorescence (510 nm) obtained after exciting the dye at 340 and 380 nm was taken as an index of Ca 2+ i . 9 The amplitude of the Ca 2+ transient and the integral of the Na + /Ca 2+ exchanger (NCX) inward current induced by rapid application of 15 mM caffeine were used to estimate sarcoplasmic reticulum (SR) Ca 2+ content.
9,13
The NCX current was measured with an Axoclamp 2A amplifier using the whole-cell voltage-clamp technique. Pipette solution contained (in mM): K-aspartate 120, KCl 20, Na 2 ATP 4, MgCl 2 4, HEPES 10, glucose 10, and GTP 0.1; titrated to pH 7.2. All experiments were performed at 308C using IS or HS supplemented with 0.1 mM ClBa. To ensure that the SR was consistently loaded with Ca 2+ , caffeine-dependent currents we measured after a 1-min rest at a holding potential of 280 mV.
Detection of spontaneous Ca 21 release by confocal microscopy
Myocytes were loaded with 10 mM fluo-3-acetoxymethyl ester and mounted on a Zeiss 410 inverted confocal microscope (LSM Tech). Cells were imaged in a linescan mode along their long axis, exciting with the 488 nm line of an argon laser and collecting emission at .515 nm. 9 Data were analysed using the 'Sparkmaster' plugin for ImageJ. 14 
Inmunodetection by western blot analysis
Samples of isolated myocytes with a 70 + 10% yield of viable cells were subjected to control isotonic or hypotonic protocols in the presence or absence of 10 mM of the guanylate cyclase inhibitor, ODQ, or 1 mM of the PKG inhibitor, KT5823. Twenty minutes after treatment with IS/IS or IS/HS, myocytes were collected and lysed with ice-cold lysis buffer for 30 min.
Proteins from myocyte suspensions were measured by the Bradford method using BSA as standard. Lysates ( 90 mg of total protein per gel line) were seeded in a 10% SDS polyacrylamide gel and transferred to polyvinylidene difluoride membranes. Blots were probed overnight with antibodies raised against phospho-Ser2808-RyR2 (Badrilla, Leeds, UK) and anti-GAPDH (Millipore, Billerica, MA, USA) for normalization. Immunoreactivity was visualized by a peroxidase-based chemiluminescence detection kit (Amersham Biosciences) using a Chemidoc Imaging System. The signal intensity of the bands in the immunoblots was quantified by densitometry using the ImageJ software (NIH).
Statistical analysis
Unpaired Student's t-test and one-way ANOVA followed by the TukeyCramer or Student -Newman -Keuls post hoc tests were used for statistical comparisons when appropriate. Data are expressed as means + SEM. Differences were considered significant at P ≤ 0.05.
Results

Hypotonic swelling promotes NO release in isolated ventricular rat myocytes
The effect of switching superfusion from an IS to a HS on cell width and DAF-FM fluorescence is depicted in Figure 1 . Figure 1A shows typical images indicating that after 20 min superfusion with HS cells maintain a well-organized sarcomere structure. Brightfield images also indicate Swelling-induced nitric oxide release in cardiomyocytes that HS noticeably enhances cell width. In contrast, cell length was not significantly enhanced, indicating that HS produces significant cell swelling without axial stretch. Control experiments show that maintaining cells in IS for an equivalent time frame does not affect cell width. Consistent with other reports, 10 there was no evidence of regulatory volume decrease (RVD) throughout the duration of the experiment. To identify the source of NO production, myocytes were superfused with HS in the absence or in the continued presence of 2.5 mM of the non-selective NOS inhibitor, L-NAME, 240 nM of the NOS1 selective inhibitor, nitroguanidine (NTG), or 1 mM of the PI3K inhibitor, Wortmannin, which has been shown to inhibit Ca 2+ -independent NOS3 activation. 7 Figure 2A shows that HS in the presence of these inhibitors produced a similar degree of cell swelling compared with HS alone. However, L-NAME and NTG completely inhibit a HS-induced increase in DAF-FM fluorescence. In contrast, Wortmannin fails to prevent NO release ( Figure 2B ). These results suggest that NOS1 is the source of swelling-induced NO release in cardiomyocytes. To confirm this, DAF-FM fluorescence was monitored in cells pretreated with Ryanodine (RY) plus cyclopiazonic acid (CPA), condition that has been shown to inhibit SR function and the therein located NOS1. 15 Figure 2C depicts overall results,
showing that HS fails to increase DAF-FM fluorescence in the absence of a functional SR. To further confirm the involvement of NOS1, by a non-pharmacological approach, we measured DAF-FM fluorescence in myocytes isolated from NOS1 knockout (KO) mice and in their wild-type (WT) controls. Figure 2D shows that superfusion with HS produced a significant increase in DAF-FM fluorescence in WT mice myocytes, and that this increase was significantly reduced in NOS1KO myoyctes. Although not attaining statistical significance, NOS1KO myocytes treated with HS showed a tendency to have higher DAF-FM fluorescence compared with NOS1KO myocytes treated with IS. These results suggest that NOS1 is the main source for NO production under hypotonic swelling. However, a minor contribution by other NOS isoforms could be expected.
Cytoskeleton integrity is required for hypotonic swelling-induced NO release
Given the deformation of cell structure promoted by osmotic water intake, we studied the impact of HS superfusion on cell membrane and TT architecture. Figure 3A shows typical fluorescence images and average results obtained in cells labelled with the lipophilic dye Swelling-induced nitric oxide release in cardiomyocytes Di-8-ANNEPS. After processing these images with a software specifically designed to evaluate TT architecture (Auto TT, University of Iowa), 12 we found that superfusion with HS produced a small nonsignificant increase in TT spacing and no change in TT integrity index [transversal elements (TEs) density multiplied by TE regularity], indicating that, under our experimental conditions, cells maintain sarcolemmal and TT integrity. Although these results suggest that there is no detubulation with HS, the increase in cell volume should still promote deformation of the microtubular network, which is known to transmit mechanical cues from cell surface to TT-SR complex. 16 The potential involvement of microtubules in the mechanotransduction of swelling-induced cell deformation to activation of NOS1 was assessed using myocytes preincubated for 2 h with 10 mM colchicine, a manoeuvre known to inhibit microtubule polymerization. 16 Figure 3B shows overall results of cell width and DAF-FM fluorescence, indicating that inhibiting microtubule polymerization does not affect the degree of cell swelling, but prevents a HS-induced increase in NO-sensitive DAF-FM fluorescence. These results suggest that microtubule integrity is required for HS-induced NOS1 activation.
Preventing NO release exacerbates the hypotonic swelling-induced negative inotropic effect
Hypotonic swelling has been well established to produce a negative inotropic effect in adult cardiomyocytes. 17, 18 However, the underlying mechanisms are not completely understood. Given that NO has been extensively shown to modulate cardiac contractility, 19 we investigated whether NO release during hypotonic swelling impacts on myocyte contractility. Superfusing myocytes with HS produces a slow developing negative inotropic effect that reaches its maximum after 15 min and then starts to recover returning to control contractility after 25 min in HS (see Supplementary material online, Figure S1 ). Figure 4A shows representative traces of twitch contractions and the associated Ca 2+ transients of a cardiomyocyte stimulated to contract at 0. Swelling-induced nitric oxide release in cardiomyocytes in the continued presence of 2.5 mM L-NAME, the HS-induced reduction in contractility and Ca 2+ transient were significantly exacerbated.
Furthermore, the spontaneous recovery of contractility observed after 25 min of superfusion with HS was lost in cells treated with L-NAME (see Supplementary material online, Figure S1 ). Overall results show that both L-NAME and 240 nM NTG exacerbate the HS-induced negative inotropic effect. The addition of L-NAME or NTG did not affect contraction and Ca 2+ transient amplitude in IS (see Supplementary material online, Figure S2 ). These results suggest that NOS1-dependent NO release contributes to sustain cardiomyocyte contractile function during hypotonic swelling.
cGMP mediates NO-induced contractile support
To explore the signalling cascade by which NO sustains contractile function during hypotonic swelling, we performed experiments in the presence and absence of 10 mM of the guanylate cylcase inhibitor, ODQ. ODQ did not affect contraction and Ca 2+ transient amplitude in IS (see Supplementary material online, Figure S2 ) nor the degree of cell swelling (see Supplementary material online, Figure S3A ). In contrast, as shown in the typical tracings and overall data depicted in Figure 4B , ODQ exacerbates the HS-induced negative inotropic effect. Interestingly, ODQ enhances the HS-induced negative inotropic effect in a similar degree than L-NAME and NTG ( Figure 4A and see Supplementary material online, Figure S4 ), confirming not only that NOS1 is the source of NO, but also that, in the setting of hypotonic swelling, the effect of NO on myocyte contraction is mediated by the cGMP signalling and not by cGMP-independent mechanisms.
Mechanisms underlying cGMP-induced contractile support
To examine whether NO/cGMP-induced contractile support was due to alterations in SR Ca 2+ handling, we measured SR Ca 2+ content and RyR2 Ca 2+ release. content. 13 Figure 5B shows that superfusion with HS or HS in the presence of ODQ did not affect the caffeine-induced I NCX compared with IS, confirming that neither the hypotonic swelling-induced negative inotropic effect nor contractile support provided by the NO/cGMP axis is determined by alterations in SR-Ca 2+ content.
We next examined the impact of HS-derived NO on SR-Ca 2+ release by monitoring Ca 2+ spark and wave dynamics as indicators of RyR2 function. Supplementary material online, Figure S5 shows that superfusing cells with HS produces a significant decrease in Ca 2+ spark frequency.
Although not attaining statistical significance, spark frequency showed Overall results show that whereas ODQ does not affect wave velocity showing HS increases RyR2 Ser2808 phosphorylation, and that both ODQ and KT5823 prevent this increase. Data are expressed as means + SEM from seven independent experiments from six hearts. *P , 0.05 vs. all groups.
Swelling-induced nitric oxide release in cardiomyocytes in IS, HS produces a significant increase in wave velocity, which is prevented by ODQ. These results suggest that NO could be sensitizing RyR2 to cytosolic Ca 2+ during hypotonic swelling.
To determine how cGMP may be affecting RyR2 function, we examined the effect of HS on the phosphorylation status of the PKA/ PKG-dependent RyR2 residue, Ser2808. Interestingly, Figure 6B shows that HS significantly increases Ser2808 phosphorylation, and that this increase is prevented by both 10 mM ODQ and 1 mM of the PKG inhibitor, KT5823. To examine whether PKG-dependent phosphorylations are involved in the inotropic support induced by NO, we evaluated the effect of HS on contraction amplitude in the presence of KT5823. Supplementary material online, Figure S6 shows that similar to L-NAME, NTG, and ODQ, inhibiting PKG exacerbates the hypotonic swellinginduced negative inotropic effect.
Discussion
The present study demonstrates, for the first time, that cell swelling promotes NO release in ventricular cardiomyocytes. Our results also suggest that NOS1 would be the primary NOS isoform responsible for NO release, being microtubule integrity required for the mechanotransduction of swelling-induced NO release. Furthermore, our results suggest that NO plays a functional role by reducing the hypotonic swelling-induced negative inotropic effect. We propose that NO via cGMP/PKG signalling enhances ryanodine receptor sensitivity to trigger Ca 2+ , which could contribute to sustain contractile function during hypotonic swelling.
Hypotonic swelling promotes NO production in rat ventricular cardiomyocytes
Recent reports in tissues other than cardiac have shown evidence, indicating that cell swelling can promote NO release. 7, 8 Moreover, we have previously reported that cardiomyocyte axial stretch promotes NO release. 6 However, cardiomyocyte swelling dilutes intracellular contents and deforms the surface membrane without significant changes in cell length. Thus, extrapolating our results from a myocyte stretch model to one of cell swelling is not straightforward. Here, we show that superfusion of cardiomyocytes with a HS, similar to other reports, 10 increases cell width, indicative of hypotonic cell swelling. This cellular swelling is associated with an increase in the fluorescence of the NO sensor, DAF-FM, which was not observed when cells were superfused with IS. In addition, whereas NOS inhibition prevented the HS-induced increase in DAF-FM fluorescence, it did not prevent cell swelling, confirming that NO production is due to the activation of NOS. There are three known isoforms of NOS within the myocardium, NOS1, NOS2, and NOS3; of which NOS1 and NOS3 are constitutively expressed. 5 Inducible NOS or NOS2 is mainly expressed during inflammatory processes. 21 To determine which NOS isoform is involved in hypotonic swelling-induced NO release, we used (i) the NOS1-specific inhibitor, NTG and (ii) the PI3K inhibitor, Wortmannin, to inhibit NOS3. This inhibitor was used taking into consideration that cardiomyocyte swelling is associated with a reduction in the Ca 2+ transient, 17, 18 and that recent reports indicate that activation of the PI3/AKT axis can alter the Ca 2+ sensitivity of NOS3 enabling NO production without a significant rise in [Ca 2+ ] i . 22 Both inhibitors failed to significantly affect the degree of cell swelling. However, whereas Wortmannin did not significantly affect HS-induced NO release, NTG completely prevented the increase in DAF-FM fluorescence. It is important to note that the fact that none of the inhibitors used, affected the degree of cell swelling, excludes the possibility that the failure to observe an increase in DAF-FM fluorescence was due to a reduction in cell swelling. Taken together, these results suggest that NOS1 is the main enzyme involved in hypotonic swelling-induced NO release. Nevertheless, these findings are at odds with a recent report indicating that, in endothelial cells, hypotonic swelling-induced NO production is mediated by Ca 2+ -independent activation of NOS3. 7 To validate our observation, we used two additional approaches: (i) given that NOS1 activation requires a functional SR, we treated myocytes with the RyR2 inhibitor, ryanodine (Ry), plus the SR Ca 2+ pump (SERCA2A) inhibitor, CPA, an intervention known to abolish SR function.
(ii) We performed experiments in myocytes from NOS1 knockout mice and their WT controls. Confirming the critical role played by NOS1, we found that HS-induced NO production was prevented in the presence of Ry + CPA and significantly reduced in myocytes from NOS1 knockout mice ( Figure 2C and D) . Interestingly, the failure to observe an increase in NO production in myocytes treated with Ry + CPA further suggests that the NOS1 isoform involved is the one localized at the SR and not the recently described mitochondrial NOS1. 15 Further insights into the mechanism underlying NOS1 activation are provided by the results showing that the inhibition of microtubule polymerization was able to prevent NO release, suggesting that microtubule integrity is required for hypotonic swelling NOS1 activation ( Figure 3B ). Although the mechanism by which the cytoskeleton may promote NOS1 activation is not clear, given the close proximity of microtubules with the SR (10 28 m) 16 it could be proposed that microtubules could intervene in the physical transmission of stress or strain from the sarcolemma to the SR resulting in NOS1 activation. Supporting this contention, various components of the cytoskeleton network have been shown to modulate NOS activity and NO production. 23 
Impact of hypotonic swelling-induced NO release on contractile function
Osmotic swelling has been shown to reduce cardiomyocyte contractility, attributed mainly to a reduction in the Ca 2+ transient. 17, 18 Brette et al. 17 showed that the slow reduction in the Ca 2+ transient induced by HS was mediated by a reduction in L-type calcium current and a decrease in SR Ca 2+ release in the absence of changes in SR Ca 2+ content.
Consistently, our results show that HS produces a slow developing reduction in contractility associated with a reduction in the Ca 2+ transient (Figure 4) . Interestingly we also show that, after reaching its maximal negative inotropic effect, contractility and Ca 2+ transient, in the continued presence of HS, start to recover in spite of the lack of RVD (see Supplementary material online, Figure S1 ). Given that NO has been shown to have varied effects on cardiac ECC, determined at least in part by different subcellular compartmentalization of NOS isoforms, 24 we examined whether hypotonic swelling-induced NO release had a functional impact on the negative inotropic effect observed during this process. Here, we show that inhibiting NO production enhances the HS-induced negative inotropic effect and prevents the contractile recovery observed when cells are maintained in HS for extended periods of time (see Supplementary material online, Figure  S2 ). Although our results do not shed mechanistic insights into the mechanism that determine the hypotonic swelling-induced negative inotropic effect, the results presented here suggest that NOS1-derived NO provides a mechanism of contractile support that prevents an even greater impact of cell swelling on cardiac contractile function. It is now well established that NO may modulate cardiac ECC both through cGMP-dependent and cGMP-independent mechanisms. 25 Our results, showing that guanylate cyclase inhibition mimics the effect of inhibiting NOS, demonstrates that cGMP-dependent mechanisms mediate NO-dependent contractile support and contractile recovery observed during hypotonic swelling.
Consistent with other reports, 17 under our experimental conditions, hypotonic swelling-induced negative inotropic effect was associated with a small, not significant, reduction in the caffeine-induced Ca 2+ transient ( Figure 4B) Figure S3 ). However, we found that, during hypotonic swelling, when Ca 2+ waves appear, their propagation velocity is significantly enhanced compared with the isotonic condition and that this increase is prevented by ODQ ( Figure 6A) It is noteworthy that an increase in RyR2 open probability as the only mechanism responsible for a positive inotropic effect is presently under debate. 27 Although our results suggest that RyR2 sensitization could have a causal role in the inotropic support provided by NO, we cannot exclude that NO could also have additional targets that could contribute to sustain contractile function during hypotonic swelling. Phosphorylation of RyR2 at site Ser2808 has been shown to increase the velocity of wave propagation. 28 Interestingly, this site is classically considered to be phosphorylated by PKA. However, in vitro experiments suggest that Ser2808 can also be phosphorylated by PKG. 29 Our results
show that RyR2 Ser2808 phosphorylation is increased by hypotonic swelling and that this increase is prevented by inhibiting cGMP ( Figure 6B ), suggesting that NO/cGMP-dependent phosphorylation of this site could be responsible for sensitizing the RyR2 to cytosolic Ca 2+ during hypotonic swelling. cGMP-dependent phosphorylation of Ser 2808 could be mediated by direct activation of PKG or by PKA, given that cGMP has also been shown to inhibit phosphodiesterases (PDEs) increasing cAMP availability and thus activating PKA. 30 Importantly, our results using the specific PKG inhibitor, KT5823, show that PKG phosphorylates RyR2 Ser2808, demonstrating, for the first time, the PKG-dependent phosphorylation of this site in a cardiac cellular model. Our results showing that KT5823, similar to L-NAME, NTG, and ODQ exacerbate the HS-induced negative inotropic effect (see Supplementary material online, Figure S4 ) indicate that NO provides contractile support, in the context of hypotonic swelling, via a cGMP/ PKG-dependent mechanism. Interestingly, the late contractile recovery observed with prolonged HS superfusion was also prevented by KT5823 treatment, suggesting that this recovery is also mediated by cGMP/ PKG-dependent mechanisms. However, we cannot exclude that other PKG-dependent mechanisms aside from the one described here (enhancement of RyR2 Ca 2+ sensitivity) could be involved in this recovery.
In summary, our results show for the first time that hypotonic swelling promotes NOS1-dependent NO release in cardiomyocytes. This NO could have multiple consequences regulating distinct cellular functions through both cGMP-dependent and independent mechanisms. Highlighting the physiopathological relevance of the NO release we described herein, we show its impact on swelling-induced contractile dysfunction, where it provides inotropic support by a cGMP/PKG-dependent mechanism. This mechanism may help to sustain contractile function in different pathological situations associated with cell swelling.
Limitations
In this study, we provide evidence showing that hypotonic swelling promotes NOS1-dependent NO release. Our results using colchicine to disrupt microtubules further suggest that the microtubular network may be involved in the mechanotranduction of cell swelling to NOS1 activation. However, the observation of a lag between cell swelling and NO production could suggest that other mechanisms, in addition to mechanical forces, could be involved. Nevertheless, this interpretetation of a more complex scenario could arise from a limitation in NO detection. Indeed, the observed lag could be due a lower sensitivity for NO detection compared with that for cell width detection. Thus, it could be conceivable that NO production could have a rather similar time course to that of changes in cell width, but is not detected until it builds up inside the cell reaching the threshold for detection. Clearly, these issues indicate that exploring the mechanisms involved in the mechanotransduction of NO release during hypotonic swelling deserves further study.
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